About Biomed Industries
Biomed Industries is a company based in San Jose (United States) founded in 2020. It operates as a B2B. Biomed Industries has completed 1 acquisition, including MedAware Systems. Biomed Industries offers products and services including NA-704, NA-831, NA-901, NA-921 (Bionetide), and NA-931 (Bioglutide). Biomed Industries operates in a competitive market with competitors including T3D Therapeutics, Alzheon, Longeveron, Alchemab and Cerecin, among others.
- Headquarter San Jose, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomed Industries, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomed Industries
Biomed Industries offers a comprehensive portfolio of products and services, including NA-704, NA-831, NA-901, NA-921 (Bionetide), and NA-931 (Bioglutide). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats Amyotrophic Lateral Sclerosis by stimulating neurogenesis.
Targets Alzheimer's disease with neuroprotection and neurogenesis.
Addresses Major Depressive Disorder with a safe profile.
Treats Rett Syndrome by crossing the blood-brain barrier.
Manages diabetes obesity via receptor agonism for weight loss.
Handles liver diseases like MASH by regulating IGF-1 function.
Delivers drugs intravenously with FDA approval for home use.
Unlock access to complete
Unlock access to complete
Funding Insights of Biomed Industries
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Biomed Industries
Biomed Industries has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MedAware Systems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scientific-Data-as-a-Service for healthcare providers
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biomed Industries
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomed Industries Comparisons
Competitors of Biomed Industries
Biomed Industries operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as T3D Therapeutics, Alzheon, Longeveron, Alchemab and Cerecin, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for neurodegenerative diseases, including Alzheimer's, are developed.
|
|
| domain | founded_year | HQ Location |
Oral inhibitors of amyloid aggregation for Alzheimer's treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cellular therapies for aging-related and life-threatening conditions are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibody based therapeutics to treat cancers, neurodegenerative conditions and infectious diseases
|
|
| domain | founded_year | HQ Location |
Medical foods and drugs for Alzheimer's disease are developed.
|
|
| domain | founded_year | HQ Location |
Genome-scale drug discovery platform is provided for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomed Industries
Frequently Asked Questions about Biomed Industries
When was Biomed Industries founded?
Biomed Industries was founded in 2020.
Where is Biomed Industries located?
Biomed Industries is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
What does Biomed Industries do?
Biomed Industries focuses on creating innovative drug therapeutics for unmet needs in areas like neurological diseases, including Alzheimers and ALS, and metabolic disorders such as diabetes and obesity. They utilize AI and machine learning to accelerate drug discovery and development through clinical trials. Based in San Jose, California, the company engages in research partnerships and FDA-approved products like the MICROS infusion system, aiming to improve patient outcomes globally without specific client disclosures.
Who are the top competitors of Biomed Industries?
Biomed Industries's top competitors include Alzheon, Longeveron and Alchemab.
What products or services does Biomed Industries offer?
Biomed Industries offers NA-704, NA-831, NA-901, NA-921 (Bionetide), and 3 more products and services.
How many acquisitions has Biomed Industries made?
Biomed Industries has made 1 acquisition, including MedAware Systems.